{
    "name": "golodirsen",
    "comment": "Rx",
    "other_names": [
        "Vyondys 53"
    ],
    "classes": [
        "Morpholino Antisense Oligomers",
        "Neurology"
    ],
    "source": "https://reference.medscape.com/drug/vyondys-53-golodirsen-1000334",
    "pregnancy": {
        "common": [
            "No human or animal data are available to assess use during pregnancy"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "No human or animal data are available to assess effects on milk production, presence in milk, or effects on the breastfed infant"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": [
                {
                    "type": "Hypersensitivity",
                    "description": [
                        "Hypersensitivity reactions, including rash, pyrexia, pruritus, urticaria, dermatitis, and skin exfoliation, reported, some requiring treatment",
                        "If a hypersensitivity reaction occurs, institute appropriate medical treatment and consider slowing the infusion or interrupting therapy"
                    ]
                },
                {
                    "type": "Renal toxicity",
                    "description": [
                        "Renal toxicity was observed in animals",
                        "Although renal toxicity was not observed in the clinical studies, renal toxicity, including potentially fatal glomerulonephritis, has been observed after administration of some antisense oligonucleotides",
                        "Monitor renal function during therapy",
                        "Because of the effect of reduced skeletal muscle mass on creatinine measurements, serum creatinine may not be a reliable measure of renal function in patients with DMD",
                        "Measure GFR by 24-hr urine collection before initiating therapy",
                        "Monthly monitoring for proteinuria by dipstick urinalysis and monitoring of serum cystatin C and urine protein-to-creatinine ratio q3Months is recommended",
                        "If confirmed dipstick proteinuria of 2+ or greater or elevated serum cystatin C, a 24-hr urine collection to quantify proteinuria and assess GFR should be performed",
                        "Only urine expected to be free of excreted drug should be used for monitoring of urine protein; urine obtained on day of infusion prior to infusion, or urine obtained at least 48 hours after most recent infusion, may be used; alternatively, use a laboratory test that does not use the reagent pyrogallol red, as this reagent has the potential to cross-react with drug excreted in the urine and thus lead to a false-positive result for urine protein",
                        "If a persistent increase in serum cystatin C or proteinuria detected, refer to a pediatric nephrologist for further evaluation"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Administration site pain",
            "percent": null
        },
        {
            "name": "Back pain",
            "percent": null
        },
        {
            "name": "Pain",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Ligament sprain",
            "percent": null
        },
        {
            "name": "Contusion",
            "percent": null
        },
        {
            "name": "Influenza",
            "percent": null
        },
        {
            "name": "Oropharyngeal pain",
            "percent": null
        },
        {
            "name": "Rhinitis",
            "percent": null
        },
        {
            "name": "Skin abrasion",
            "percent": null
        },
        {
            "name": "Ear infection",
            "percent": null
        },
        {
            "name": "Seasonal allergy",
            "percent": null
        },
        {
            "name": "Tachycardia",
            "percent": null
        },
        {
            "name": "Catheter site",
            "percent": null
        },
        {
            "name": "related reaction",
            "percent": null
        },
        {
            "name": "Constipation",
            "percent": null
        },
        {
            "name": "Fracture",
            "percent": null
        }
    ]
}